NEW YORK (GenomeWeb News) – Affymetrix said in a filing with the US Securities and Exchange Commission today that it expects to close its acquisition of eBioscience next month rather than in the fourth quarter, as originally announced.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.